Introduction
Tobacco smoking is the leading cause of preventable death worldwide, whereas quitting smoking is an effective way to prevent many diseases and premature mortality. 1 An increasingly large body of information about the harms of smoking and a greater availability of treatment programs has led to a growing effort among smokers to quit, however more than 95% of smoking cessation efforts fail within a year. 2 Moreover, even though more than 70% of smokers report that they are interested in quitting, most continue smoking. 3 One factor that may hinder smoking cessation is the presence of depression symptoms and anxiety. The positive reinforcing effects of nicotine may improve mood, cognition, and anxiety.
Abstinence, in turn, may exacerbate these symptoms.
Despite the higher prevalence of anxiety and depression in smokers, studies conducted with Brazilian populations
have been unsuccessful to demonstrate the association between these symptoms and failure to stop smoking. 4, 5 In order for a smoker to quit, nicotine dependence needs to be counterbalanced by a high degree of motivation to stop smoking. Because smoking cessation may be a very difficult goal for those unable or unwilling to quit smoking, a reduction in cigarette consumption can be an initial step towards changing behavior and achieving complete abstinence. [6] [7] [8] Smoking reduction may increase the chance of future cessation because it reduces dependence, discontinues conditioning, and increases self-efficacy. 8, 9 Thus, reduced tobacco use signals that the smoker is motivated to change, and should therefore be considered a positive outcome. 7 About two-thirds of the smokers trying to quit fail in the first week. This rate is similar for both treated 10 and untreated smokers. 2, 11 The first days post-quit day seem to be the most difficult ones, because, in addition to learning a new behavior, smokers have to cope with withdrawal symptoms and cognitive and emotional difficulties. 12 Notwithstanding, resisting smoking in the first moments after quitting is essential, as these symptoms tend to remain stable. 13 Smokers who manage to remain abstinent and survive the first days without tobacco are more likely to succeed in the long term 11, 14 and less likely to have lapses or to relapse, 10 probably because they feel encouraged and motivated. 2, 10 Conversely, it is very common, in the treatment setting, to have patients that stop attending therapeutic group activities or consultations because they have failed to quit smoking or have relapsed. 15 In view of the above, most attempts to quit smoking fail prematurely, and our understanding of this process remains inaccurate. 
Methods Procedures
This short-term cohort study was conducted in a free- and the Brazilian National Cancer Institute. 19 At the beginning of the first session, participants were asked to sign an informed consent form. Subsequently, they answered a self-administered questionnaire covering sociodemographic characteristics, smoking history, nicotine dependence, motivational stages, and anxiety and depression symptoms. The second session focused on planning the quitting attempt and provided information on withdrawal signs and symptoms, risk situations, coping strategies, and relaxation exercises.
In this session, the quit day for each participant was set.
In the third session, difficulties faced during the attempt to stop smoking were approached, and strategies to maintain abstinence were reinforced. The last session focused on relapse prevention and reinforcement of skills and strategies for those who did not achieve abstinence. A total of 183 smokers attended the first session.
After application of our inclusion and exclusion criteria, 163 smokers were enrolled in the study. Only two smokers had quit smoking before starting the support group, and they were not more than 7 days abstinent.
Only 54 smokers (33.1%) completed the four sessions of the study. Figure 1 shows the patient selection process and dropout rates. 
Measures

Statistical analysis
Baseline data were analyzed considering all enrolled smokers. Conversely, the analysis of changes in smoking behavior included only retained smokers, i.e., those who attended all four sessions of the support group.
For the analysis of retained smokers, groups were created based on self-reported smoking habits, confirmed by cotinine concentrations in urine samples.
As a result, smokers were divided into two groups: 1) smokers who kept smoking (similar cotinine urinary concentrations in the first and fourth sessions); and 2) smokers who completely quit smoking, or at least reduced tobacco intake (confirmed by a 40% or greater reduction in cotinine concentrations from the first to the fourth session Table 1 shows the characteristics of the smokers included in the study, as well as characteristics of 
Results
FTND question
Cotinine concentration p Table 1 -Demographic characteristics of the smokers included in the study, n (%) SD = standard deviation. * Percentages refer to the column. † Percentages refer to the total value (row). ‡ p < 0.01.
attendance of the four sessions of the smoking cessation program (p = 0.001 and p < 0.001, respectively) ( Table   3 ). Correlating these scores with differences in urinary cotinine concentrations revealed similar changes in both parameters, regardless of whether or not the smokers had changed their tobacco consumption habits (Figure 3 ).
The study also evaluated the authenticity of self- 
Discussion
The first days of an attempt to quit smoking represent an important challenge for long-term abstinence.
This study found that more than 60% of the smokers are unable to achieve their goal of changing tobacco consumption patterns, even when they had fully attended a smoking cessation program. Worst of all, only 12% of those who attended the first program meeting were able to effectively stop or reduce smoking, either because they did not attend the whole program or because they did not remain abstinent. Better news is that, for smokers who were able to at least reduce the amount of tobacco smoked daily, the intensity of nicotine dependence decreased and scores of motivational maintenance increased.
In the FTND scale, time to the first cigarette of the day and number of cigarettes smoked per day seemed to provide the best information for assessing intensity of nicotine dependence; data originating from these questions added appreciably to the prediction of biochemical levels of cotinine. In fact, some questionnaires use only these two questions to measure nicotine dependence, but the other questions contained in the FTND may serve to improve our understanding of smokers' behaviors. 21 Nicotine dependence is frequently pointed out as a powerful predictor of the failure to achieve abstinence. Smokers who do not quit usually have higher levels of nicotine dependence. [34] [35] [36] In the same way, smokers who reach cessation are supposedly those who are less nicotine dependent. Nevertheless, our results do not corroborate these statements.
Evidently, FTND scores decreased with the smokers' attempts to reduce or quit smoking, indicating that they had The association between advanced motivational stages and smoking reduction or cessation has been identified in previous studies, 42, 43 but not in our sample. Smokers who did not change their tobacco consumption presented higher baseline maintenance stage scores when compared to smokers who reduced tobacco consumption or quit, which suggests that even highly motivated smokers may not be fully ready to stop smoking. Similarly, Boardman et al. 44 showed that smokers who did not manage to quit presented high levels of motivation and self-efficacy due to the hope of quitting in the next attempt.
In this study, anxiety symptoms did not show a relationship with the cessation/reduction process. Our result diverges from others found in the literature that report higher numbers of anxiety symptoms in more dependent smokers, especially women, and a decreased anxiety among individuals who remain abstinent. 16, 45 This could be related to limitations of the study, including the small sample size and the short period of analysis.
Moreover, another study by our group found that higher anxiety levels were associated with a lower probability of the smoker keeping the treatment. 46 Here it is important to consider that we included in this analysis only 48 and affect the process of smoking cessation in those who seek interventions to change their habit, heightening the probability of failure or relapse. 49 Nicotine is known to act on neural circuits associated with affect regulation, 50 and individuals will smoke to relieve feelings of sadness or negative affect, effectively using nicotine as a remedy for depression symptoms. 51 As a result, quitting is more difficult for those who are depressed, who would have to learn a new skill to cope with sadness symptoms. Our results, however, did not uncover any differences among the groups in the periods analyzed, probably because the smokers who remained in treatment had low levels of depression symptoms to begin with.
Despite the recognized efficacy of group therapy for smoking cessation, adherence to group programs is a barrier to tobacco control; 23% of the participants leave treatment within the first month, and around 45% leave it within 2 months. 48, 52 In our study, adherence to the support group was even lower, with only 33.1% of the individuals attending all the meetings over 1 month. Poor adherence is also a problem in group treatment of other addictions; for example, only around 20% of alcoholics in Brazil continue attending Alcoholics Anonymous meetings after 6 months of follow-up. 53 Comparing the approaches used here with studies conducted in other countries may be disappointing, mainly due to intrinsic characteristics of support groups in Brazil. Usually, recruitment is carried out reactively, and the participation of patients is not subject to any kind of incentive, especially financial ones.
The results of the present study should be considered with care. First, the small sample size, combined with the large number of dropouts, limits generalization of the findings. Also, we did not include a diagnostic assessment of past or present psychopathology or a more fine-grained analysis of the personal characteristics of patients, which may have interfered with smoking cessation. Also, the study included subjects who enrolled in a clinical setting, and therefore not be representative of all smokers.
Smoking cessation is a dynamic process. learned to report lower levels of dependence is a factor deserving further investigation. Greater knowledge about the motivation, dependence and comorbidity related to smoking will allow professionals to be better prepared to treat smokers, with more effective treatment plans and interference strategies tailored to these characteristics.
